Objectives: To report demographic and clinical data on 98 myasthenia gravis (MG) patients,
seen over 5 years (January 2014-December 2018). Methods: This was a retrospective …

Objective: To report demographic and clinical data on 98 myasthenia gravis (MG) patients,
seen over five years (January 2014-December 2018). Background: MG is an autoimmune …

Objectives: To investigate the distribution of muscle weakness in Myasthenia gravis (MG)
and the therapeutic response in each category. Methods: This is a retrospective cross …

Introduction: Myasthenia gravis (MG) is an autoimmune disorder of neuromuscular junction
associated with presence of antibodies against nicotinic acetylcholine receptors (nAChRs) …

Myasthenia gravis (MG) has a cosmopolitan distribution and can affect people of all
agegroup. Sometimes atypical presentation causes difficulty in the early diagnosis and …

Myasthenia gravis (MG) is a rare neuromuscular disorder. Till now, there are no studies on
the prevalence and incidence of MG in Mongolia. The current study aimed to elucidate the …

Background: Myasthenia gravis (MG) is a neuromuscular junction disorder usually
associated with a thymic lesion. Aims and Objective: To study the clinical, serological, and …

Introduction: A limited number of research studies were published to delineate the clinical
pattern of myasthenia gravis in Saudi Arabia. This paper is an attempt to describe some of …

Background: Myasthenia gravis is an autoimmune disorder affecting the neuromuscular
junction. Signs and symptoms present a wide spectrum ranging from only ocular symptoms …

Background: Myasthenia Gravis (MG) is a potentially treatable disease among many
neuromuscular disorders. Different demographic, clinical and laboratory characteristics may …